Saturday, February 25, 2006


Hepatitis C Combination Therapy - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Hepatitis C Combination Therapy - A Summary of Chronic Hepatitis C InfectionHepatitis C

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Friday, February 24, 2006


Hepatitis C Combination Therapy - Advances in Viral Hep -- Hep C, a Clinical update


Advances in Viral Hep -- Hep C, a Clinical update
Hepatitis C combination therapy with viramidine and peginterferon alfa-2a reduces potential for ribavirin-related hemolytic anemia. Gastroenterology. 2004;126(suppl 2

Hepatitis C Combination Therapy
Hepatitis C Combination Therapy Articles Information Links Hepatitis C Combination Therapy Related Excerpt from our homepage : " Many STDs cause

hepCuk.info
Ribavirin, used in hepatitis C combination therapy should not be used during pregnancy. Ribavirin is known to cause severe birth defects and any woman of child bearing age or man with a female

Introduction to the hepatitis C Virus
approves combination antiviral therapy using interferon and ribavirin for patients with chronic hepatitis C. Combination therapy

Hepatitis C Combination Therapy - 4-pronged attack in war on drugs


4-pronged attack in war on drugs
Ottawa Sun, Canada - Feb 9, 2006... An average of 300 people seek treatment outside the region each year. - Ottawa has a 21% rate of HIV and Hepatitis C infection among intravenous drug users. ...

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

Schering-Plough drug gets fast track
BusinessWeek - Jan 30, 2006... The drug, known as SCH 503034, is an oral therapy in mid-stage human studies testing it as a treatment for chronic hepatitis C infection. ...

Transgene Awarded EUR 1.3 M Grant for Hepatitis C Therapeutic ...
Canada NewsWire (press release), Canada - Jan 25, 2006... About Hepatitis C: Hepatitis C infection is a major public health problem with around 170 to 200 million people infected worldwide. ...

ZymoGenetics Reports Fourth Quarter and Year End 2005 Financial ...
International News Service, Australia - Feb 9, 2006... Other -- The company decided to advance Interleukin-29 (IL-29) into clinical development as a potential treatment for Hepatitis C infection. ...

Thursday, February 23, 2006


Hepatitis C Combination Therapy - Introduction to the hepatitis C Virus


Introduction to the hepatitis C Virus
approves combination antiviral therapy using interferon and ribavirin for patients with chronic hepatitis C. Combination therapy

hepatitis c confirmatory test - page: 5
hepatitis c combination therapy abrasion c hepatitis liver relating Oysco 500 Oysco 500 Chewable Oysco D INTERESTING TOPICS: Tocopherol see Vitamin E Pimple Palpitations

All About Hepatitis C - Approved Treatments for Hepatitis C
used alone (referred to as monotherapy) or in combination with an antiviral agent called ribavirin (referred to as combination therapy) for the treatment of chronic hepatitis C. Combination therapy

Hepatitis C Combination Therapy - Ultrasound


Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Wednesday, February 22, 2006


Hepatitis C Combination Therapy - Hepatitis C: Index | CDC Viral Hepatitis


Hepatitis C: Index | CDC Viral Hepatitis
Living with Chronic Hepatitis C. English Language version Abobe; Spanish Language version Abobe; Russian Language version Abobe. Hepatitis C Prevention ...

Hepatitis C
The diagnosis of chronic hepatitis C is made by history, ... Most patients with chronic hepatitis C will be asymptomatic or have non-specific symptoms such ...

Hepatitis B and C -- familydoctor.org
What are chronic hepatitis B and chronic hepatitis C? *, How does a person get hepatitis B or C? *, What are the symptoms of acute hepatitis B or C? ...

Chronic Hepatitis C: Current Disease Management
Explains the causes and symptoms of hepatitis C, along with information about diagnosis and treatment.

Hepatitis C: FAQ | CDC Viral Hepatitis
Can children receive interferon therapy for chronic hepatitis C? ... It is common for persons with chronic hepatitis C to have a liver enzyme level that ...

Symptoms of Chronic Hepatitis C - WrongDiagnosis.com
Symptoms of Chronic Hepatitis C including medical symptoms and signs of Chronic Hepatitis C, symptoms, incubation period, duration, and correct diagnosis ...

Hepatitis C Combination Therapy - Hepatitis B


Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Hepatitis C Combination Therapy - HEPATITIS C INFORMATION PACKET


HEPATITIS C INFORMATION PACKET
THERAPIES FOR HEPATITIS C COMBINATION THERAPY Treatment with interferon (monotherapy) clears the virus to undetectable levels in approximately 10-20% of people infected with HCV

c hepatitis sign symptom,c hepatitis pcr, - page: 5
hepatitis c combination therapy c hepatitis research trial disability and hepatitis c hepatitis c confirmatory test end stage hepatitis c c combination hepatitis therapy

ROCHE LAUNCHES NEW CAMPAIGN ABOUT HEPATITIS C
There is no vaccine available for hepatitis C. Combination therapy results in better treatment responses than monotherapy, but the highest response rates have been achieved with pegylated interferon

Semin Liver Dis
Interferon in the Treatment of Chronic Hepatitis C Combination Therapy With Interferon alfa and Ribavirin

AMFAR Treatment Insider
Both of these options could cut the price of hepatitis C combination therapy. Rebetron costs approximately $18,000 a year. One U.S. pharmacy already sells ribavirin separately, for roughly a fifth of

Cost-Effectiveness of Epoetin Alpha for the Management of Anemia
Cost-effectiveness of Epoetin Alpha for the Management of Anemia During Hepatitis C Combination Therapy Anemia is a common adverse effect of Hepatitis C

Tuesday, February 21, 2006


Hepatitis C Combination Therapy - Pill Form of Therapy for HCV Coming Closer


Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Hepatitis C Combination Therapy - Hepatitis C


Hepatitis C
... Yeast infection STI overview Chlamydia Gonorrhea Hepatitis B Hepatitis C Herpes Genital warts Pelvic Inflam ... What is hepatitis C? Hepatitis C is a serious liver disease that ...

Hepatitis C Association, Hepatitis C awareness, donor support, and education
The focus of the Hepatitis C Association is to educate the public, both medical professionals and private citizens, about hepatitis C virus

Health: Hepatitis C
Hepatitis C Abstract: Hepatitis C Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). HCV is spread when body fluids, primarily blood from an infected person enters the body of a person who is not infected. Note: Persons ...

Monday, February 20, 2006


Hepatitis C Combination Therapy - Genotyping - HCV News Articles


Genotyping - HCV News Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and experimental vaccines for Hepatitis C.

Hepatitis C Top Articles
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in ... Is HCV Viral Load a Predictor of Progression of Chronic Hepatitis C? ...

HIV and HCV - Liver Health Information - The American Liver Foundation
HCV stands for the hepatitis C virus. It is the virus that causes hepatitis C. ... If you have HIV/HCV co-infection, then you have both HIV and HCV. ...

HCV Advocate Newsletter
The HCV Advocate newsletter is a valuable resource designed to provide the hepatitis C community with monthly updates on events, clinical research, ...

Kilauea Volcano
Many of the members of Hawaii Center for Volcanology are working on Kilauea or have gained insights into the nature of volcanoes from visiting it. ...

Hawaii Center for Volcanology
Information and research on Hawaiian Volcanoes by the University of Hawaii.

Hepatitis C Combination Therapy - What is Hepatitis C?(NC)-Hepatitis C is an infectious

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Sunday, February 19, 2006


Hepatitis C Combination Therapy - 4-pronged attack in war on drugs


4-pronged attack in war on drugs
Ottawa Sun, Canada - Feb 9, 2006... An average of 300 people seek treatment outside the region each year. - Ottawa has a 21% rate of HIV and Hepatitis C infection among intravenous drug users. ...

ZymoGenetics Reports Fourth Quarter and Year End 2005 Financial ...
International News Service, Australia - Feb 9, 2006... Other -- The company decided to advance Interleukin-29 (IL-29) into clinical development as a potential treatment for Hepatitis C infection. ...

HAART reduces liver-related death risk, but hepatitis C infection ...
Aidsmap, UK - Jan 18, 2006Highly active antiretroviral therapy (HAART) reduces the risk of liver-related death by 68%, although infection with both HIV and hepatitis C virus (HCV ...

Schering-Plough drug gets fast track
BusinessWeek - Jan 30, 2006... The drug, known as SCH 503034, is an oral therapy in mid-stage human studies testing it as a treatment for chronic hepatitis C infection. ...

Hepatitis C Combination Therapy - Hepatitis C Patients Taxing Medical System


Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....